Preferential dedication to epilepsy.
Dr. Antonio Gil-Nagel Rein is an international reference in epilepsy care, dissemination and research, especially in the diagnosis and treatment of candidates for epilepsy surgery, and epileptic and developmental encephalopathies. He graduated in Medicine and obtained his PhD degree at the Complutense University of Madrid. He completed his specialty in Neurology at the Hospital Universitario 12 de Octubre and Fellowships at the Minnesota Comprehensive Epilepsy Centre. He practiced neurology in the USA at the University of Minnesota and Gillette Children’s Hospital, Minneapolis and Rush Medical Centre, Chicago.
Since 1998 he has been Director of the Epilepsy Unit at the Ruber Internacional Hospital in Madrid, a pioneering center in the diagnosis and medical and surgical treatment of epilepsy in children and adults. More than 150 neurologists and neurophysiologists from Spain and Latin America have been trained there, and several of his students have successfully developed epilepsy centers in other public and private hospitals, both in Spain and abroad. The program he directs was a pioneer in Spain in the genetic diagnosis of complex epilepsies and advanced therapies such as drug repositioning, interstitial laser treatment, deep electrodes and gamma radiosurgery, which have been applied in patients with refractory epilepsy.
Dr. Antonio Gil-Nagel is associated as a professor at IE University, is Ad Honorem Professor at the Center for Biomedical Technology of the Polytechnic University of Madrid (CTB), and directs the Chair of Epilepsy at the Francisco Vitoria University of Madrid. He was one of the founding members of the European Epilepsy Research Network and the European Epilepsy Monitoring Association. He also collaborates actively in international research projects, such as EpiCare and the European Epilepsy Brain Bank and has held relevant positions in international institutions, such as the International Bureau of Epilepsy (IBE) of the International League Against Epilepsy (ILAE), the European Federation of Neurological Societies (EFNS) and the World Federation of Neurology (WFN).
Dr. Gil-Nagel has led multiple clinical trials and scientific research in epilepsy, especially in orphan epilepsies such as Dravet syndrome, Lennox-Gastaut syndrome and other epileptic and developmental encephalopathies. The Epilepsy Program he directs is an international reference in the development of pharmacological research. He has been principal investigator in phase II and III clinical trials with numerous clinical trials and non-pharmacological treatments (epilepsy surgery, electrical stimulation, ketogenic diet and Gamma Knife). His research is funded by European Union Funds and the State Innovation Agency of the Ministry of Science and Innovation of the Government of Spain. His dedication to research and development of new treatments allows him to accelerate the treatment of his patients with novel therapies.
In addition to being a frequent lecturer at national and international meetings, he is the author of several books on epilepsy and electroencephalography, and has numerous publications on epilepsy in journals such as Annals of Neurology, Brain, Epilepsia, European Journal of Neurology, Journal of Neurology, Nature Neurology, Neurology and New England Journal of Medicine, among others. He is the author of 165 articles indexed in Scopus with 5,265 citations and an h-index of 35.
In 2021 his team received the “Innovative SME” Award for the Mesial Temporal Epilepsy and Encephalocele Project (Ministry of Science and Innovation, Spain) and in 2012 the Scientific Award of the Epilepsy Group of the Spanish Society of Neurology (SEN).
Degree in Medicine and Surgery
Universidad Complutense de Madrid, 1985Neurology Specialist
Hospital 12 Octubre, Madrid 1986-1989Epilepsy Specialist
Minnesota Comprehensive Epilepsy Program
University of Minesotta, Minneapolis, USA, 1991-1993American Board of Clinical Neurophysiology, 1997
Assistant Professor
Epilepsy Program and Department of Neurology
University of Minesotta, Minneapolis, USA, 1993-1995Assistant Professor
Epilepsy Program and Department of Neurological Sciences
Rush-Presbyterian-St. Luke’s Medical Center, Chicago, USA, 1995-1998Director of the Epilepsy Program
Neurology Service, Hospital Ruber Internacional, Madrid, 1998.Doctor of Medicine
Universidad Complutense de Madrid, 2014
Thesis: Clinical and neurophysiological study in the pre-surgical evaluation of epilepsy.Associate Chief of Service. Neurology Service, Hospital Ruber Internacional, Madrid, 2022
- Since 2009- Member of the Educational Course Committee: “European Federation of Neurological Societies”.
- Since 2009- Member of the Scientific Committee, World Congress of Neurology, “World Federation of Neurology”, Marrakesh 2011
- Since 2008- Director of the Epilepsy Group of the European Federation of Neurological Societies.
- Since 2006- Representative of Spain, “World Federation of Neurology”.
- Since 2006- Member of the Editorial Board and website of “World Federation of Neurology”.
- Since 1996 Member of the American Clinical Neurophysiology Society.
- Since 1991 Member, American Academy of Neurology.
- Since 1991 Member, American Epilepsy Society.
- Since 1988 Member of “Sociedad Española de Neurología”.
- 2007-09 Member of the Scientific Committee of the “European Federation of Neurological Societies”.
- 2007-08 Vice-president of the Scientific Committee, “12th Congress of the European Federation of Neurological Societies”, Madrid, August 2008
- 2004-07 Delegate of Spain in “European Federation of Neurological Societies”.
- Honorary Member of the Epilepsy Association of Madrid.
- 2011 Scientific Award of the Epilepsy Group of the Spanish Society of Neurology.
